Please login to the form below

Not currently logged in
Email:
Password:

BenevolentAI appoints new head of cheminformatics

Dr Nathan Brown joins from the Institute of Cancer Research

Artificial Intelligence (AI) group BenevolentAI has appointed Dr Nathan Brown as its new head of cheminformatics.

Brown joins the group from the Institute of Cancer Research (ICR), where he founded and led the new In Silico Medicinal Chemistry Group, which focussed on medicinal chemistry research towards novel cancer treatments.

He also has experience as a software designer and has developed many novel algorithms to maximise the impact of the experimental data generated in medicinal chemistry and cancer biology.

Jackie Hunter, CEO of BenevolentBio, the bioscience subsidiary of BenevolentAI, said: “Nathan is a recognised leader in the field of cheminformatics, molecular informatics and computational chemistry.

“He has done exceptional work in the development of innovative anti-cancer therapies in an academic setting and his work is respected and well published. We are delighted to have him on board.”

Brown succeeds Mark Davies who has been promoted to vice president, Biomedical Informatics.

1st August 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...